Evaxion expands AI platform into autoimmune disease research
Go back to Evaxion expands AI platform into autoimmune disease research| (NASDAQ: EVAX) | Delayed: 3.89 +0.18 (4.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.71 | 52 Week High | $ | |||
| Open | $3.96 | 52 Week Low | $ | |||
| Day High | $3.98 | P/E | N/A | |||
| Day Low | $3.65 | EPS | $ | |||
| Volume | 65,408 | |||||



